The global liver cancer therapeutics market size was valued at USD 1,730.9 million in 2019 and is projected to grow from USD 2,037.5 million in 2020 to USD 7,382.1 million by 2027, exhibiting a CAGR of 20.2% during 2020-2027 period. North America dominated the liver cancer therapeutics market with a market share of 63.91% in 2019.